EGFR and cancer: Epidermal growth factor receptor (EGFR), which is a receptor tyrosine kinase (RTK), initiates multiple signaling pathways related to cancer progression, such as those involved in cell proliferation, migration/invasion and the cell cycle [4]–[7].